Alex Sharif | Director, Investor Relations and Corporate Development |
Mitchell Gold | Executive Chairman and Chief Executive Officer |
Stanford Peng | President and Head of Research and Development |
Paul Rickey | Chief Financial Officer |
Ted Tenthoff | Piper Sandler |
Mark Breidenbach | Oppenheimer |
Joe Pantginis | H.C. Wainwright |
Good afternoon, ladies and gentlemen, and thank you for joining the Alpine Immune Sciences Fourth Quarter 2020 Financial Results and Corporate Update Conference Call. Currently all participants are in a listen-only mode.
Following the management prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this conference call is being recorded today, Thursday, March 18th, 2021. I would now like to introduce Alex Sharif, Director, Investor Relations and Corporate Development.